Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options
 Orrstown Financial Services ORRF 25. avr 2025 28.75 -0.14   
 Orthofix Medical OFIX 25. avr 2025 14.19 +1.72   
 OrthoPediatrics KIDS 25. avr 2025 21.54 -1.01   
 Oruka Therapeutics ORKA 25. avr 2025 10.09 -3.90   
 OS Therapies OSTX 25. avr 2025 1.60 -0.62   
 Oscar Health A OSCR 25. avr 2025 12.23 +1.66   
 Oshkosh OSK 25. avr 2025 88.78 +0.08   
 OSI Systems OSIS 25. avr 2025 201.68 -0.31   
 Osisko Development ODV 25. avr 2025 1.65 -2.94   
 Osisko Gold Royalties OR 25. avr 2025 23.35 -0.09   
 OSR Holdings OSRH 25. avr 2025 1.38 0.00   
 Ostin Technology Group OST 25. avr 2025 2.71 -2.17   
 Otis Worldwide OTIS 25. avr 2025 92.93 +0.20   
 Otter Tail OTTR 25. avr 2025 77.89 -1.57   
 Ouster OUST 25. avr 2025 7.98 +3.37   
 Outbrain OB 25. avr 2025 3.83 +0.79   
 Outfront Media OUT 25. avr 2025 15.06 +0.47   
 Outlook Therapeutics OTLK 25. avr 2025 1.53 -1.29   
 Outset Medical OM 25. avr 2025 11.58 +6.63   
 Ovid Therapeutics OVID 25. avr 2025 0.35 +3.00   
 Ovintiv OVV 25. avr 2025 34.67 +0.41   
 Owens & Minor OMI 25. avr 2025 6.95 -0.29   
 Owens Corning OC 25. avr 2025 144.08 +0.08   
 Owlet A OWLT 25. avr 2025 3.77 +9.59   
 Oxbridge Re OXBR 25. avr 2025 1.31 +1.55   
 Oxford Industries OXM 25. avr 2025 51.91 +1.11   
 Oxford Lane Capital OXLC 25. avr 2025 4.57 +0.66   
 Oxford Lane Capital 2027 Pref OXLCP 25. avr 2025 24.17 -0.25   
 Oxford Square Capital OXSQ 25. avr 2025 2.55 +4.51   
 P10 PX 25. avr 2025 11.21 +0.18   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.